2-Nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 10g

2-Methyl-2-phenylpropanenitrile, 97.0%, 25g

(E)-1,2-Di(pyridin-4-yl)ethene, 98%, 5g

Planifique un objetivo IOS PLPOLi 20x/0,40 sin estrés para la polarización incidente de iScope, sin corrección de cubreobjetos. Distancia de trabajo 5,8 mm

(4S,5S)-1,3,4,5-tetraphenyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate, 98%, 1g

Maleimide-DOTA, 100mg

Ethyl (Phenylthio)acetate, 97.0%, 10g

Cyclopropanecarbaldehyde, 95.0%, 25g

EXO-(3-OXA-BICYCLO[3.1.0]HEX-6-YL)-METHANOL, 95.0%, 1g

4-(5-((PYRIDIN-3-YLMETHYL)AMINO)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)BENZAMIDE, 95%, 25mg

3,5-Difluoro-4-(propan-2-yloxy)benzoic acid, 95.0%, 250mg

ETHYL 2-NITRO-4-(TRIFLUOROMETHYL)PHENYLACETATE, 95.0%, 1g

tert-Butyl 4-(5-chloro-2-fluorobenzylamino)piperidine-1-carboxylate, 1g